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Developing recommendations for prostate cancer prevention requires identification of modifiable risk
factors. Maternal exposure to high-fat diet (HFD) initiates a broad array of second-generation adult
disorders in murine models and humans. Here, we investigate whether maternal HFD in mice affects
incidence of prostate hyperplasia in offspring. Using three independent assays, we demonstrate that
maternal HFD is sufficient to initiate prostate hyperproliferation in adult male offspring. HFD-exposed
prostate tissues do not increase in size, but instead concomitantly up-regulate apoptosis. Maternal
HFD-induced phenotypes are focally present in young adult subjects and greatly exacerbated in aged
subjects. HFD-exposed prostate tissues additionally exhibit increased levels of activated Akt and deactivated
Pten. Taken together, we conclude that maternal HFD diet is a candidate modifiable risk factor for prostate
cancer initiation in later life.

wudosis.wustl.edu)
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rostate cancer (PCa) is the second most commonly diagnosed cancer in western males, and 1 in 36 American
men will die of this disease1. In 2010, the estimated total economic burden of prostate cancer in the United
States was $11.5 billion2. To lessen this burden on society, modifiable risk factors must be identified, but the
only known risk factors for PCa – age, ethnicity, and familial history – are not modifiable1. The role of preventable
factors such as diet and environment in the development of PCa is not clear3,4. For example, obesity appears to be
associated with incidence of PCa, but only with advanced cases5,6.
The Fetal Origins of Adult Disease hypothesis posits that perinatal environmental factors generationally
transmit to their offspring predisposition to certain diseases that may present during adulthood7. Our group
and others have shown that several disease conditions in offspring are influenced by maternal obesity during the
gestational period, which we define as the peri-conception, in utero, and lactation periods. For example, maternal
overnutrition and gestational diabetes mellitus contribute to a wide range of second-generation cardiometabolic
disorders in both humans and rodent models8–10. Furthermore, disorders such as congenital malformations11,
autism12, asthma and atopic conditions13,14, and behavior syndromes such as attention deficit hyperactive disorder15 are also subject to fetal programming. In murine models, maternal perinatal high-fat diet (HFD) impairs
the quality of female gametes and leads to meiotic aneuploidy, embryonic loss, growth retardation, and brain
defects in offspring16. Thus, a wide variety of embryonic and adult disorders are programmed by maternal
gestational diet, which is modifiable.
One identifying marker of human and murine prostate cancers is disrupted activity of the tumor suppressor
Phosphatase and tensin homolog (Pten)17–19. Pten, a protein- and lipid-phosphatase, is part of the Protein Kinase B
(Akt) pathway, which ubiquitously regulates cell growth and survival18. In the canonical Akt pathway, ligandbound receptor tyrosine kinases stimulate Phosphatidylinositol 3-kinase (PI3K) to convert phosphatidylinositol
4,5-bisphosphate (PIP2) to phosphatidylinositol (3,4,5)-triphosphate (PIP3)20. Akt binds to PIP3 at the plasma
membrane and undergoes post-translational modifications, such as activating Serine 473 phosphorylation20,21.
Activated Akt then phosphorylates downstream targets to regulate cell behaviors including proliferation and
programmed cell death; hyperactivation of this pathway is thus a frequent cause of tumor growth21,22. Pten
converts PIP3 to PIP2, thereby antagonizing PI3K and inhibiting Akt signaling17,18. Endogenous phosphorylation
of certain Pten residues, such as Serine 380, can inhibit Pten activity and permit Akt-driven proliferation23,24.
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Thus, hyperphosphorylation of Pten at Serine 380 is permissive of
proliferation and is a potential mechanism of prostate hyperplasia.
Here, we examine the possibility that maternal HFD transmits a
predisposition for prostate proliferation in murine adult offspring.
Although murine models are thought to require genetic or chemical
insults to initiate PCa25, our data demonstrate that maternal exposure
to HFD during gestation is sufficient to program hyperproliferation
and increased apoptosis in dorsolateral prostate (DLP) tissue of adult
offspring. This phenomenon is focally present in some acini in young
adult and middle-aged mice and is dramatically intensified in older
subjects. The data demonstrate that normal changes in homeostasis
patterns that occur with aging are exacerbated by perinatal maternal
HFD. Additionally, we demonstrate that Pten and Akt are both
hyperphosphorylated in prostates from offspring of HFD-fed
mothers. These data suggest that the prostate hyperproliferation
occurs because of activation of the Akt pathway. Furthermore, as
Pten is a cardinal prostate cancer tumor suppressor17, these findings
suggest that gestational high-fat diet is a risk factor for PCa initiation
in later life.

Results
Maternal high-fat diet stimulates prostate hyperplasia in male
offspring. Four-week-old C57Bl/6J female mice were fed control
(chow, 13% kcal from fat) or high-fat (HFD defined by Surwit et
al26.; 59.4% kcal from fat) diets throughout life. After one month of
dietary exposure, dams were mated to chow-fed C57Bl/6J studs. All
resulting pups remained with their mothers until weaning at
postnatal day 21 (P21) and then were kept on chow diets until
sacrifice (diagrammed in Fig. 1). Chemically and genetically driven
prostate cancers exhibit latency periods in murine models19,27. Thus,
mice were aged to young adulthood (16 weeks), middle age (26
weeks), and old age (63 weeks) before sacrifice, DLP lobe isolation,
and blinded expert histological analysis.
Very few of the acini in DLP samples from 16-week-old chowexposed mice showed evidence of hyperproliferation (mean 1.92% 6
0.51%, range 0%–7.9%). Although not statistically significant, the
number of hyperproliferative prostate acini was nearly two-fold
higher in DLP samples from 16-week old HFD-exposed mice than
in those from chow-exposed mice (Figure 2a–b; mean 3.44% 6
0.93%, range 0%–13.6%). Some regions of prostates from 16-week
old HFD-exposed mice exhibited increased intraluminal secretory
cells with mainly tufted architectures, without nuclear atypia (inset).
By 26 weeks of age, the difference in numbers of hyperproliferative
acini between chow- and HFD-exposed mice was significant (Chow:
mean 3.95% 6 0.66%, range 0%–9.6%; HFD: mean 7.01% 6 1.11%,
range 0%–17.24%). At this time, cribriform architecture was also
detected in HFD-exposed mice (Fig. 2d, inset). The difference in
hyperproliferation was even more pronounced in 63-week-old subjects (Chow: mean 2.19 6 0.53%, range 0–8.47%; HFD: mean 4.28 6
0.50%, range 0–7.69%). Furthermore, in some foci the gland luminal
spaces were nearly filled with hyperplastic secretory cells (Fig. 2e–f,
inset). These data suggest that gestational exposure to HFD stimulates hyperproliferation in the prostates of offspring and that hyperproliferation may be exacerbated in aged subjects.
To confirm these findings, tissue sections from chow- and HFDexposed pups were assayed for expression of Ki67, a marker of proliferation. Prostates from chow-exposed 63-week-old mice exhibited
significantly (P , 0.0001) more proliferation than those from the 16week-old cohort, suggesting that proliferation normally increases as
C57Bl6/J mice age (Fig. 3g). Additionally, as histological analysis of
tissue morphology suggested, prostate samples from HFD-exposed
pups demonstrated increased expression of Ki67 (Fig. 3). The difference in percent of Ki67-positive cells per image between chow- and
HFD-exposed mice was significant at all time points (Fig. 3g). Most
dramatically, 62.03% 6 1.51% of cells were Ki67 positive in prostates
from 63-week-old HFD-exposed offspring (Fig. 3 e–g). At this time
SCIENTIFIC REPORTS | 3 : 3466 | DOI: 10.1038/srep03466

Figure 1 | A murine maternal high-fat diet model. Four-week-old C57Bl/
6J female mice were fed either chow or high-fat diet for at least four weeks
to expose developing oocytes to the respective diets. Starting at eight weeks
of age, dams were mated to chow-fed C57Bl/6J males. Males were removed
and switched back to chow diets after four days. All resulting pups
remained with the mother until weaning and then were maintained on
chow diets until sacrifice at 16, 26, or 63 weeks. Pups were exposed to highfat diet during peri-conception, gestation, and lactation.

point, only 17.65% 6 0.90% of cells in prostates from chow-exposed
offspring were Ki67 positive. The ranges of Ki67-positive events at
this age were extensive (chow: 0.72%–51.79%; HFD: 16.71%–
93.17%) and represented a 23-fold difference between HFD and
chow at the lowest values. These observations suggest that normal
Ki67 expression increases with age and is intensified by gestational
HFD exposure.
To further corroborate the findings from histological analyses and
Ki67 indices, some of the mice from each timepoint were subjected to
intraperitoneal BromodeoxyUridine (BrdU) injections 24 hours
before sacrifice. As expected, BrdU labeling was largely absent in
chow-exposed animals. Cases of BrdU positive cells in controls,
which were almost exclusively observed in samples from 63-weekold mice (Fig. 4e), were generally couplets undergoing isolated proliferation events. By contrast, cases of isolated proliferation events
were evident in 16-week-old HFD-exposed offspring (Fig. 4b) and
were common in 26-week-old HFD-exposed animals (Fig. 4d).
Strikingly, 63-week-old HFD-exposed offspring exhibited focal,
intense uptake of BrdU. Whereas only proliferating couplets were
detected in some acini, the majority of the cells were BrdU-positive in
other acini (Fig. 4f). Taken together, these three assays indicate that
maternal HFD exposure initiates prostate proliferation events in
adulthood that are exacerbated in older animals.
2
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Figure 2 | Gestational high-fat diet stimulates hyperproliferation in the prostate. (a–f) H & E staining of prostate acini from chow- (a, c, and e) and
HFD-exposed (b, d, and f) offspring at 16 (a and b), 26 (c and d), and 63 (e and f) weeks of age. Insets are high-magnification images to illustrate
the most marked morphological defects in prostates from HFD-exposed animals, including tufted (b), and cribriform growth patterns (d and f), but a lack
of nuclear atypia. (g) Quantification of the numbers of hyperproliferative acini per slide in prostates from chow- and HFD-exposed offspring at 16, 26,
and 63 weeks of age. N $ 2 samples per mouse from $7 mice, scale bars 5 100 mm.

Maternal HFD exposure stimulates hyperapoptotic compensatory
mechanisms. Given the hyperproliferation observed in prostates from
HFD-exposed offspring, we investigated whether prostates were enlarged in these animals. Body weights were not significantly different
between those exposed to chow or HFD during gestation (Table 1).
Similarly, weights of the en bloc excised urogenital sinus (UGS)
regions and the DLP lobes showed no correlation with gestational
diet exposure at any time point (Table 1).
Wild-type C57Bl/6J mice do not spontaneously develop prostate
tumors; they require genetic and/or chemical insults to initiate and
recapitulate human prostate cancer19,25,27,28. Thus, C57Bl/6J HFDexposed murine models might maintain homeostatic mechanisms
that protect against environmental insults such as maternal high-fat
diet. To assess this possibility, we used terminal deoxynucleotidyl
transferase-mediated dUTP nick-end labeling (TUNEL) to calculate
apoptosis indices in prostates from 16-, 26- and 63-week-old mice
born to chow- or HFD-exposed mothers. At 16 weeks, apoptosis was
slightly more frequent in prostate acini from HFD-exposed mice
than in those from chow-exposed mice (Fig. 5a–b, g; chow: mean
10.65% 6 2.12%, range 0%–32.54%; HFD: mean 17.42% 6 2.63%,
range 0%–48%). At 26 weeks, no significant difference in apoptosis
was observed in prostates from HFD- and chow-exposed offspring
(Fig. 5c–d, g). Strikingly, HFD-exposed offspring in the oldest age
group demonstrated a mean apoptosis index of 27.53% 6 2.38%
(Fig. 5f, g; range 0%–73.4%). In contrast, the mean apoptotic index
of 63-week-old chow-exposed animals was significantly lower
(Fig. 5e, g; 7.86% 6 1.06%, range 0%–24%). Thus, trends in apoptotic
indices of adult HFD-exposed animals were exacerbated in older
SCIENTIFIC REPORTS | 3 : 3466 | DOI: 10.1038/srep03466

animals, mirroring the hyperproliferation phenotypes described
above. Taken together, these data demonstrate that in young and
middle-aged animals, gestational HFD initiates focal hyperproliferation. In older animals, increased levels of apoptosis may compensate
for the highly elevated hyperproliferation such that no net tissue
growth occurs.
Maternal high-fat diet induces activating Akt and inhibitory Pten
post-translational modifications in prostate tissue. We sought to
identify the mechanism by which hyperplasia is stimulated in
prostates from HFD-exposed animals. As the tumor suppressor
Pten inhibits proliferation via the Akt pathway21 in non-cancerous
prostate tissue, we investigated Akt phosphorylation at Serine 47321
in offspring by two methods, western blot detection and fluorescent
intensity analysis. At 16 weeks, western blot detection demonstrated
that, whereas there was no difference in levels of total Akt, prostates
from HFD-exposed mice had 4.35-fold more Phospho-(Serine 473)
Akt than prostates from chow-exposed mice (Fig. 6a–c). Similarly,
fluorescent intensity analysis demonstrated that prostates from 63week-old HFD-exposed animals had equivalent levels of total Akt
but higher levels of Phospho-(Serine 473)-Akt than those from
chow-fed animals, (Fig. 6d–i). Together, these data demonstrate
that maternal gestational high-fat diet activates Akt signaling in
prostate tissue.
Given that Pten normally antagonizes PI3K and inhibits Akt signaling, we next investigated whether Pten was deactivated in these
animals. At 16 weeks, there was no difference in levels of total Pten,
but Phospho-(Serine 380)-Pten was 3.79-fold higher in prostates
3
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Figure 3 | Maternal high-fat diet exposure stimulates expression of Ki67. (a–f) Ki67 staining (black) of prostate acini from chow- (a, c, and e) and HFDexposed (b, d, and f) offspring at 16 (a and b), 26 (c and d), and 63 (e and f) weeks of age. Arrows indicate Ki67-positive nuclei. (g) Quantification
of the percentage of Ki67-positive cells per image. N $ 71 images from $7 animals per condition, scale bars 5 100 mm.

from HFD-exposed offspring than in those from chow-exposed offspring (Fig. 6j–l). Similarly, prostates from 63-week-old HFDexposed animals had equivalent levels of total Pten but higher levels
of Phospho-(Serine 380)-Pten than chow-exposed animals (Fig. 6m–
r). These collective data indicate that Pten deactivation and Akt
activation accompany the hyperplasia observed in prostates from
HFD-exposed offspring.

Discussion
Here, we identify a novel risk factor for prostate hyperproliferation:
maternal high-fat diet from periconception to weaning. Our observations indicate that hyperproliferation occurs throughout the lifecourse and is exacerbated in aged subjects. Gestational HFD
exposure did not result in altered prostate weights, due in part to
compensatory apoptosis. Pten and Akt hyperphosphorylation in
these animals provides one explanatory mechanism for the observed
hyperplastic phenotypes. Collectively, these data introduce gestational HFD exposure as a novel risk factor for prostate cancer in later
life.
This work provides a relatively simple murine model to initiate
prostate hyperproliferation. To our knowledge, this is the first study
to consider the effects of gestational HFD on fetal programming of
prostate cancer predisposition. Importantly, the phenotype stimulated by gestational high-fat diet resembles early phases of prostate
dysplasia: focal hyperplasia that in some cases, after a long latency
period, results in abnormal and widespread proliferation25. Although
we did not observe tumor formation, we found that gestational HFD
deactivates the tumor suppressor Pten, permitting atypical Akt activity. Pten is commonly lost in aggressive prostate cancers29,30; thus, our
Pten/Akt signaling data imply that gestational HFD exposure predisposes murine offspring to potentially aggressive prostate cancers,
SCIENTIFIC REPORTS | 3 : 3466 | DOI: 10.1038/srep03466

rather than benign foci. If this is the case, we expect that concomitant
dietary exposure and genetic or chemical ‘second hits’ would result in
aggressive prostate intraepithelial neoplasia (PIN) and carcinoma in
situ phenotypes. Such investigations are a critical avenue of future
research.
Disruption or loss of Pten gene products (either genetically or
post-transcriptionally) is very common in human and murine
aggressive prostate tumors29–31,17,18. However, specific alterations in
Pten post-translational inhibition, such as phosphorylation as
observed here, provide an attractive mechanism to explain individual
disparities in prostate cancer outcomes. The Pten-Akt pathway is an
established mediator of insulin receptor signaling18,32. Evidence has
also linked Pten-Akt signaling to lipid metabolism through sterolregulatory element-binding proteins33. Pten additionally regulates
apoptosis and senescence in prostate cells, particularly after oxidative
stress34. All of these pathways are disrupted by gestational overnutrition35. It is possible that post-translational regulation of the Pten-Akt
pathway, and thus cell homeostasis, depends on gestational exposure
conditions. This may explain the diverse array of outcomes observed
in prostate cancer incidence. Obesity rates are rising in the western
world; in 2010, approximately 30% of reproductive-age American
women were obese36. If individual gestational exposures contribute
to human prostate cancer risk, then we speculate that future generations will present a more severe, and possibly unpredictable, array of
prostate cancer outcomes. However, careful characterization of
gestational exposures may identify specific dietary risk factors and
abrogate this outcome.
Our data revealed that hyperplasia was stimulated by high-fat diet
at all of the tested timepoints. In particular, we observed significantly
more hyperplasia in HFD-exposed 63-week-old animals than in
younger counterparts. These older animals also exhibited a statistically
4
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Figure 4 | Maternal high-fat diet exposure stimulates increased uptake
of BrdU in prostates. (a–f) BrdU (green) incorporation into prostates
from chow- (a, c, and e) and HFD-exposed (b, d, and f) offspring at 16 (a
and b), 26 (c and d), and 63 (e and f) weeks of age. Nuclei are stained with
TO-PRO-3 (blue). Arrow indicates BrdU-positive nuclei, scale bars 5
50 mm.

significant rise in apoptosis, which presumably accounted for the lack
of difference in prostate size between these animals and chow-exposed
controls. HFD-induced upregulation of apoptosis could be explained
by several mechanisms: First, apoptosis mechanisms could be operating normally in these animals. In this case, HFD-driven Akt signaling and hyperplasia could trigger checkpoints that cause an apoptotic
response. This would be most prevalent in older subjects, which had

highly elevated hyperplasia rates. Second, given that Pten regulates
apoptosis37, HFD could concurrently deregulate hyperplasia and
apoptosis by deregulating Pten activity. Finally, gestational diet could
deregulate both Pten/Akt-driven proliferation and another independent pathway, leading to an upshift in apoptosis. Studies in conditional
murine genetic models with impaired checkpoints or apoptosis could
identify the prevailing mechanism underlying this observation.
This study identified a relatively broad developmental window
that was influential in programming prostate hyperproliferation.
Animals were exposed to HFD during the entire perinatal period
because mice do not spontaneously exhibit prostate cancer. Thus,
the strong phenotype reported herein was an unexpected result.
During periconception, gestation, and early post-natal growth, multiple developmental events occur that could be perturbed by HFD
exposure. One possibility is that maternal HFD disrupts the oocyte or
zygote. De novo DNA methylation is established during maternal
folliculogenesis, and then modified again at fertilization38. Methylation of mono-allelically expressed imprinted genes is perturbed in
prostate cancer cell models and aggressive prostate cancer foci39–42.
For example, expression of the imprinted gene Insulin-like Growth
Factor 2 (IGF2) is deregulated in prostate cancer lesions43. IGF2
signals through IGF receptors 1, 2, and insulin receptor. IGFR1
and insulin receptor stimulate signaling through multiple pathways
including the Akt cascade44, which we observed to be disturbed by
gestational HFD-exposure. Thus, we speculate that gestational diet
could deregulate IGF2 imprinting which would in turn alter signaling at its receptors, Pten/Akt signal transduction, and subsequent
homeostasis in offspring. It will be important to explore the influence
of gestational diet on both gene-specific and global epigenetic signatures in future research.
Another possibility is that maternal HFD affects prostate development postnatally. Rodent prostate development is incomplete until
postnatal day 1545, and early postnatal exposures have been demonstrated to induce prostate hyperplasia and PIN46. Thus, HFD exposure during lactation may program proliferation rates, perhaps by
influencing Akt-dependent cell signaling. Future studies must parse
out the specific exposure window by honing down the timing of HFD
exposure in these animals.
Consumption of a high-fat diet is an established modifiable risk
factor for many types of cancer, and obesity leads to adverse outcomes in patients with aggressive prostate cancer47. Unfortunately,
specific time windows in the patients’ lifespans and individual dietary risk factors for aggressive prostate cancer initiation have not been
clearly delineated5,6,48, and the influences of the perinatal and early
developmental time windows on prostate cancer health are relatively
unstudied49. The data presented here provide evidence that the perinatal time window is important for patterning prostate health.
Exposures during this timeframe can now be tracked in human
subjects and manipulated in animal models. It should be noted that
other cancer predispositions are also subject to perinatal dietary

Table 1 | Maternal high-fat diet does not change weight of offspring prostate tissue

16 week
26 week
63 week

Body Weight (g)
UGSa Weight (g)
DLPb Weight (mg)
Body Weight
UGS Weight
DLP Weight
Body Weight
UGS Weight
DLP Weight

CHOW 6 sd

n

HFD 6 sd

n

P

27.93 6 2.19
0.53 6 0.13
0.0232 6 0.005
29.85 6 1.99
0.67 6 0.11
0.0269 6 0.008
38.26 6 5.45
1.19 6 0.50
0.0293 6 0.001

16
16
15
6
6
6
8
8
8

26.46 6 2.18
0.49 6 0.05
0.0252 6 0.008
29.52 6 3.58
0.64 6 0.11
0.0274 6 0.007
37.28 6 4.12
1.13 6 0.38
0.0272 6 0.009

15
15
12
5
5
5
10
10
6

0.062
0.225
0.453
0.853
0.697
0.909
0.661
0.785
0.687

a

Urogenital Sinus;
Dorsolateral Prostate.

b
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Figure 5 | Maternal high-fat diet stimulates apoptosis in 63-week old prostate tissue of male offspring. (a–f) TUNEL (green) of prostate acini from
chow- (a, c, and e) and HFD-exposed (b, d, and f) offspring at 16 (a and b), 26 (c and d), and 63 (e and f) weeks of age. Nuclei are stained with TO-PRO-3
(blue). (g) Quantification of the percentage of TUNEL-positive cells per image. N $ 32 images from $7 mice, scale bars 5 50 mm.

exposures. For example, gestational diet programs mammary tumor
development in both first- and second-generation female rodent
offspring50,51. Multigenerational effects of perinatal HFD also predispose offspring to reproductive and pituitary tumors; these studies
have indicated that maternal diet is particularly influential during the
early postnatal period52,53. Recent epidemiological work found that
the distance between the pelvic and iliac crests, which is hormonally
controlled, in the mother positively correlated with prostate cancer
incidence in male offspring54. The current data provide an intriguing
counterpart to these previous findings; a gestational high-fat environment may program hyperplasia in many hormone-responsive tissues. Taken together, these findings could lead to a recommendation
that maternal diet be more tightly regulated to prevent adverse cancer outcomes in offspring as they age.

Methods
Animal husbandry. All animals were handled with IUCAC approval by the
Washington University Animal Studies Committee, Animal Welfare Assurance
protocol # A-3381-01. Three groups of 10 C57Bl/6J four-week old male and female
mice were obtained from The Jackson Laboratories (Bar Harbor, ME). Mice were
housed five per cage in standard 12-hour light/dark conditions with ad libitum access
to food and water. For each breeding cycle, five age-matched female mice were fed
either control chow diet (PicoLab Rodent Diet 20; 13.2% of calories from fat) or
standard high-fat diet (TestDiet, 58R3; 59.4% of calories from fat)26. High-fat- and
control-fed dams were mated to age-matched males (that were diet-exposed for #4
days). Resulting pups remained with their mother until weaning, after which they
were maintained on control chow diets until sacrifice. Male offspring were sacrificed
at 16, 26, and 63 weeks of age. five animals per diet were given intraperitoneal
injections of 5-Bromo-2-Deoxyuridine (BrdU [30 mg/kg]; Sigma-Aldrich, St. Louis,
MO) for 24 hours prior to sacrifice. At sacrifice, UGS regions were removed en bloc to
cold PBS (pH 7.4), and DLPs were disassociated (as previously described55,56) and
fixed in 4% paraformaldehyde overnight. Prostates were dehydrated to 70% ethanol,
processed overnight, and paraffin embedded. Four levels were sectioned onto glass
Posi-Slides (Lab Storage Systems, Inc.).
Hematoxylin and Eosin (H & E) staining. Sections (6 mm) were deparaffinized in
three changes of xylene for 5 minutes (59) each and rehydrated for 29 in each of the
following: 100% Ethanol (EtOH), two changes of 95% EtOH, and two changes of
water. Sections were stained in CAT Hematoxylin (BioCare Medical) for 79 and
washed for 29 in running water. Slides were differentiated with one dip in 0.5%

SCIENTIFIC REPORTS | 3 : 3466 | DOI: 10.1038/srep03466

acid-alcohol solution, washed for 19 in running water, blued with 1 dip in 0.2%
ammonia water, washed for 59 in running water, rinsed in 95% alcohol for 29, and
counterstained for 30 seconds in Accustain Eosin Y Solution (Sigma-Aldrich, St.
Louis, MO). Slides were dehydrated for 29 in each of the following: 70% EtOH, 95%
EtOH, and two changes of 100% EtOH. Slides were then cleared for 59 in xylene and
mounted in Cytoseal XYL (Richard-Allan Scientific). Two slides per animal were
analyzed for percent hyperproliferative acini per slide (quantification modified
from57) by an investigator blinded to the feeding regimen.
Immunohistochemistry (IHC) and immunofluorescence (IF). Sections (6 mm)
were processed as previously described58. Briefly, sections were deparaffinized,
rehydrated, quenched in H2O2/methanol solution, and boiled for 309 in 10 mM
sodium citrate solution for antigen retrieval. Sections were permeabilized in 0.2%
TritonX-100 in PBS for 159, blocked in 10% goat serum/5% BSA in PBS, and
incubated with a-Ki67 antibody (Abcam, 15250), a-Pten (Cell Signaling Technology
15200), a-Phospho (Ser380) Pten (Cell Signaling Technology, 15200), a-Akt (Cell
Signaling Technology, 15200), or a-Phospho (Ser473) Akt (Cell Signaling
Technology, 15200) overnight at 4uC (all antibodies were raised in rabbit). Slides were
washed in PBS and incubated for 1 hour at room temperature in either HRP- (Santa
Cruz Biotechnology, 152500) or Alexa Fluor 488/568-conjugated (Molecular
Probes,151000) secondary antibodies raised in goat. For IHC: Slides were washed,
developed for 59 by using a Vector DAB Kit (Vector Laboratories) per manufacturer’s
protocol, counterstained for 30 seconds in CAT Hematoxylin, rehydrated, and
mounted with Cytoseal-XYL. Sections were imaged on a Nikon Eclipse E800 upright
microscope with an Olympus DP71 camera and manufacturer’s software. The
average percent of Ki67-positive cells was determined by counting cells in 15 images
per slide and two slides per mouse. For IF: Sections were counterstained with TOPRO-3 iodide 642 and mounted with Vectashield. Imaging was performed by
confocal microscopy (Nikon D-Eclipse-C1 E800; Nikon EZ-C1si image Capture
software Bronze Version 3.80). Prostate epithelium regions were selected in
Photoshop CS6, and pixel intensities were measured in ImageJ and normalized to
total cell count.
BrdU labeling. Sections (3 mm) were baked at 55uC for 109 directly before labeling.
Sections were deparaffinized with two xylene washes for 59 each and rehydrated with
sequential 29 incubations in each of the following: two changes in each of 100% EtOH,
95% EtOH, and 70% EtOH, and then incubated in PBS for 59. Antigen retrieval was
performed as described above. Slides were cooled, treated with DNaseI (5 U/mL, Life
Technologies) for 309 at 37uC, washed, and blocked in 3% BSA/0.1% Tween-20/PBS
for 309 at room temperature. Sheep anti-BrdU (Abcam, 15200) was applied in 1510
dilution of blocking buffer overnight at 4uC. Slides were washed in PBS and labeled
with Alexa Fluor 488 secondary antibody (Life Technologies, 15100) for 309 at room
temperature, and TO-PRO-3 iodide 642 (Life Technologies, 15500) was applied for 59
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Figure 6 | Akt (Serine 473) and Pten (Serine 380) are hyperphosphorylated in prostates from offspring of HFD-exposed mothers. From 16-week old
chow and HFD-exposed animals: Representative images are given of Phospho-(Serine 473) Akt, total Akt (a), Phospho-(Serine 380) Pten, total Pten (j) and
cyclophilin (loading control; a & j) proteins present in 16-week old dorsolateral prostates from chow and HFD-exposed animals. Quantifications of
normalized Phospho-(Serine 473) Akt (b), Total Akt (c), Phospho-(Serine 380) Pten (k) and Total Pten (l) protein signal are presented, n 5 3 animals per
condition. From 63-week old chow and HFD-exposed animals: Representative images of Phospho-(Serine 473) Akt (d–e) Total Akt (g–h), Phospho-(Serine
380) Pten (m–n) and Total Pten (p–q) from chow- and HFD-exposed dorsolateral prostate tissue sections. Normalized fluorescence intensities are
quantified in each subsequent graph (f, i, o, r), n 5 5 animals per condition, all scale bars 5 10 mM.

at room temperature. Slides were mounted in Vectashield mounting medium (Vector
Laboratories Inc.). Imaging was performed on a confocal microscope as above.

exposed for ,30 seconds. Bands from each condition were quantified with ImageJ.
Data were normalized to cyclophilin loading controls and statistically compared.

TUNEL assay. TUNEL assays were performed by using a Fluorescein In Situ Cell
Death Detection Kit (Roche Diagnostics) according to the manufacturer’s protocol.
Sections were counterstained with TO-PRO-3 iodide 642 and mounted with
Vectashield. Slides were visualized by confocal microscopy as above, and the average
percent of TUNEL positive cells was calculated from 15 images from each of 2 slides
per animal.

Statistical analyses. Data are from $7 chow- or high-fat-diet-exposed animals at
each timepoint. Each data point (n) is individually represented in the graphs;
horizontal bars represent the mean. All errors values are the SEM. P values were
determined in two-tailed unpaired students t-tests with Prism 6 Software
(GraphPad).

Western blotting. Whole 16-week murine dorsolateral prostates were excised,
washed in PBS, and homogenized in RIPA buffer supplemented with Protease
(Roche) and Phosphatase Inhibitors (Sigma). Samples were rotor-stat homogenized,
spun at 14,000 RPM for 59, and supernatants were aliquotted and stored at 280uC.
BCA assays (Thermo Scientific) were used to calculate total protein concentrations.
Standard western blotting methodologies were used, with acrylamide gels separated
for 3 hours at 50 V. After transfer, blots were blocked in 5% non-fat dry milk solution
for 1 hour at room temperature. Membranes were incubated in primary antibody
overnight at 4uC in heat-sealed bags. Primary antibodies were the same as used above;
all were diluted 151000. Membranes were washed and incubated with HRPconjugated secondary antibodies (Santa Cruz, 1510,000) for 1 hour at room
temperature. Membranes were treated with ECL reagent (Bio Rad). Films were
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